How much will Nivolumab cost in 2023?

Nivolumab (Nivolumab) is a drug called a monoclonal antibody that works by helping the immune system slow or stop the growth of cancer cells. It is used alone or in combination with ipilimumab to treat certain types of melanoma (a type of skin cancer) in adults and children over 12 years of age that have spread to other parts of the body or cannot be removed with surgery; it is also used alone to prevent melanoma from coming back after surgery.

Nivolumab may also be used alone or in combination withipilimumab and/or other chemotherapy drugs to treat certain types of lung cancer (non-small cell lung cancer), renal cell carcinoma (a cancer that starts in the cells of the kidneys), Hodgkin lymphoma, head and neck cancer, urothelial cancer (the lining of the bladder and cancers in other parts of the urethra), colorectal cancer (cancer that begins in the large intestine), hepatocellular carcinoma (HCC; a type of liver cancer), esophageal cancer (cancer in the tube that connects the throat to the stomach), gastric cancer (or gastroesophageal junction cancer (cancer located at the junction of the stomach and esophagus)), and malignant pleural mesothelioma (a cancer that affects the lining of the lungs and chest cavity).

The generic drug nivolumab is currently on the market in China, but it has not yet been included in medical insurance. This drug is a strictly controlled drug, and its purchase channels are restricted. The price of 40mg/4ml box may be around 4,000 yuan, and the price of 100mg/10ml box may be around 7,000 yuan. The Turkish version of the nivolumab antigenic drug marketed overseas may cost more than RMB 2,000 per box of 40 mg/4ml, and may cost more than RMB 5,000 per box of 100 mg/10 ml (the price may fluctuate due to exchange rates). There is currently no generic version of nivolumab available on the market. For more drug information and specific prices, please consult a medical consultant.